vaginal neoplasms

Summary

Summary: Tumors or cancer of the VAGINA.

Top Publications

  1. pmc The economic burden of noncervical human papillomavirus disease in the United States
    Delphine Hu
    Program in Health Decision Science, Department of Health Policy and Management, Harvard School of Public Health, Boston, MA 02115, USA
    Am J Obstet Gynecol 198:500.e1-7. 2008
  2. ncbi Intrauterine exposure to diethylstilbestrol: long-term effects in humans
    S H Swan
    Department of Family and Community Medicine, University of Missouri, Columbia 65212, USA
    APMIS 108:793-804. 2000
  3. ncbi The distribution of low and high-risk HPV types in vulvar and vaginal intraepithelial neoplasia (VIN and VaIN)
    Monica Srodon
    Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, MD 21231, USA
    Am J Surg Pathol 30:1513-8. 2006
  4. ncbi Vaginal metastasis and thrombocytopenia from renal cell carcinoma
    Jay E Allard
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Walter Reed Army Medical Center and the National Naval Medical Center, Washington, DC, USA
    Gynecol Oncol 92:970-3. 2004
  5. ncbi Treatment of vaginal intraepithelial neoplasia with laser ablation and upper vaginectomy
    Emmanuel Diakomanolis
    Colposcopy and Laser Surgery Unit, 1st Department of Obstetrics and Gynecology, Alexandra Hospital, Athens University, Athens, Greece
    Gynecol Obstet Invest 54:17-20. 2002
  6. ncbi Laparoscopic management of vaginal clear cell adenocarcinoma arising in pelvic endometriosis: case report and literature review
    Ali Mahdavi
    Division of Gynecologic Oncology and Minimally Invasive Surgery, Department of Obstetrics, Gynecology and Reproductive Science, Mount Sinai School of Medicine, New York, New York 10036, USA
    J Minim Invasive Gynecol 13:237-41. 2006
  7. ncbi Renal cell carcinoma presenting as a perineal mass: case report and review of the literature
    Gary Wayne Mendese
    Department of Pathology, University of Massachusetts Medical School, Worcester, Massachusetts 01655, USA
    Urology 67:847.e1-2. 2006
  8. ncbi Upper vaginectomy for the treatment of vaginal intraepithelial neoplasia
    Megan D Indermaur
    Department of Gynecology Onclogy, University of South Florida, Tampa, FL, USA
    Am J Obstet Gynecol 193:577-80; discussion 580-1. 2005
  9. ncbi Robotically-assisted laparoscopic radical parametrectomy and radical vaginectomy
    J P Geisler
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Toledo, OH 43614, USA
    Eur J Gynaecol Oncol 32:674-6. 2011
  10. doi Descriptive epidemiology of vaginal cancer incidence and survival by race, ethnicity, and age in the United States
    Xiaocheng Wu
    Louisiana Tumor Registry, Louisiana State University Health Sciences Center, New Orleans, Louisiana 70112, USA
    Cancer 113:2873-82. 2008

Detail Information

Publications178 found, 100 shown here

  1. pmc The economic burden of noncervical human papillomavirus disease in the United States
    Delphine Hu
    Program in Health Decision Science, Department of Health Policy and Management, Harvard School of Public Health, Boston, MA 02115, USA
    Am J Obstet Gynecol 198:500.e1-7. 2008
    ....
  2. ncbi Intrauterine exposure to diethylstilbestrol: long-term effects in humans
    S H Swan
    Department of Family and Community Medicine, University of Missouri, Columbia 65212, USA
    APMIS 108:793-804. 2000
    ..The importance of dose and gestational age at initial exposure are discussed, and the implications of DES findings for the evaluation of risks from current EDCs emphasized...
  3. ncbi The distribution of low and high-risk HPV types in vulvar and vaginal intraepithelial neoplasia (VIN and VaIN)
    Monica Srodon
    Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, MD 21231, USA
    Am J Surg Pathol 30:1513-8. 2006
    ..Finally, comparison of the distribution of HPV in the vagina and vulva suggests that VaIN is more closely related to cervical intraepithelial neoplasia than to VIN...
  4. ncbi Vaginal metastasis and thrombocytopenia from renal cell carcinoma
    Jay E Allard
    Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Walter Reed Army Medical Center and the National Naval Medical Center, Washington, DC, USA
    Gynecol Oncol 92:970-3. 2004
    ..Vaginal cancer represents approximately 1-2% of genital tract malignancies. Most cases represent metastasis from the cervix, endometrium, or colon. Metastasis of renal cell carcinoma to the vagina is extremely rare...
  5. ncbi Treatment of vaginal intraepithelial neoplasia with laser ablation and upper vaginectomy
    Emmanuel Diakomanolis
    Colposcopy and Laser Surgery Unit, 1st Department of Obstetrics and Gynecology, Alexandra Hospital, Athens University, Athens, Greece
    Gynecol Obstet Invest 54:17-20. 2002
    ....
  6. ncbi Laparoscopic management of vaginal clear cell adenocarcinoma arising in pelvic endometriosis: case report and literature review
    Ali Mahdavi
    Division of Gynecologic Oncology and Minimally Invasive Surgery, Department of Obstetrics, Gynecology and Reproductive Science, Mount Sinai School of Medicine, New York, New York 10036, USA
    J Minim Invasive Gynecol 13:237-41. 2006
    ..She was treated with neoadjuvant chemoradiation, laparoscopically assisted radical vaginal hysterectomy, radical upper vaginectomy, and pelvic lymphadenectomy followed by combination chemotherapy...
  7. ncbi Renal cell carcinoma presenting as a perineal mass: case report and review of the literature
    Gary Wayne Mendese
    Department of Pathology, University of Massachusetts Medical School, Worcester, Massachusetts 01655, USA
    Urology 67:847.e1-2. 2006
    ..This case illustrates the variability in RCC presentation. Also, because vaginal clear cell carcinoma is rare, all such lesions should be considered potentially renal in origin...
  8. ncbi Upper vaginectomy for the treatment of vaginal intraepithelial neoplasia
    Megan D Indermaur
    Department of Gynecology Onclogy, University of South Florida, Tampa, FL, USA
    Am J Obstet Gynecol 193:577-80; discussion 580-1. 2005
    ..The purpose of this study was to evaluate the use of upper vaginectomy for the treatment of vaginal intraepithelial neoplasia (VAIN)...
  9. ncbi Robotically-assisted laparoscopic radical parametrectomy and radical vaginectomy
    J P Geisler
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Toledo, OH 43614, USA
    Eur J Gynaecol Oncol 32:674-6. 2011
    ..A similar operation, radical vaginectomy, is rarely performed because of the its technical difficulty in getting adequate margins without an attached uterus...
  10. doi Descriptive epidemiology of vaginal cancer incidence and survival by race, ethnicity, and age in the United States
    Xiaocheng Wu
    Louisiana Tumor Registry, Louisiana State University Health Sciences Center, New Orleans, Louisiana 70112, USA
    Cancer 113:2873-82. 2008
    ..It has many of the same risk factors as cervical cancer, including a strong association with persistent human papillomavirus infection. Descriptive studies of the epidemiology of vaginal cancer are scarce in the literature...
  11. doi Vaginectomy: a minimally invasive treatment for cervical cancer vaginal recurrence
    Pierluigi Benedetti Panici
    Department of Gynecology, Perinatology and Child Health, University of Rome La Sapienza, Viale del Policlinico, Rome, Italy
    Int J Gynecol Cancer 19:1625-31. 2009
    ..We investigated the possible role of vaginectomy for isolated vaginal relapse (IVR) in cervical cancer (CC)...
  12. pmc Risk of human papillomavirus-associated cancers among persons with AIDS
    Anil K Chaturvedi
    Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, 6120 Executive Blvd, EPS 7072, Rockville, MD 20852, USA
    J Natl Cancer Inst 101:1120-30. 2009
    ....
  13. ncbi Salvage treatment with high-dose-rate brachytherapy for isolated vaginal endometrial cancer recurrence
    Patrick Petignat
    Department of Gynecologic Oncology, Centre hospitalier de l Université de Montréal CHUM Hôpital Notre Dame, Montreal, Quebec, Canada
    Gynecol Oncol 101:445-9. 2006
    ..To evaluate the outcome of patients with recurrent vaginal endometrial cancer treated with high-dose-rate brachytherapy (HDRB) and external beam radiation therapy (EBRT)...
  14. pmc Protein expression patterns in primary carcinoma of the vagina
    K Hellman
    Department of Gynecologic Oncology, Radiumhemmet, Karolinska Hospital, S 171 76 Stockholm, Sweden
    Br J Cancer 91:319-26. 2004
    ..There might, further, be a possibility to identify tumour-specific markers among the proteins that are differentially expressed. The results from this study have to be confirmed by more comprehensive studies in the future...
  15. ncbi A recurrent gain of chromosome arm 3q in primary squamous carcinoma of the vagina
    Jens K Habermann
    Genetics Branch, Center for Cancer Research, National Cancer Institute NIH, Building 50, Room 1408, 50 South Drive, Bethesda, MD 20892 8010, USA
    Cancer Genet Cytogenet 148:7-13. 2004
    ..Age at diagnosis (P=0.031), tumor size (P=0.025), and increased laminin-5 expression (P=0.006) have a significant influence on the survival time...
  16. ncbi High-dose-rate interstitial brachytherapy for gynecologic malignancies
    Sushil Beriwal
    Department of Radiation Oncology, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA
    Brachytherapy 5:218-22. 2006
    ..The study aimed to assess the outcome of locally advanced cervical and vaginal cancer treated with high-dose-rate interstitial brachytherapy (HDRB)...
  17. ncbi Blue nevi of the Müllerian tract: case series and review of the literature
    Kenneth J Craddock
    Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada
    J Low Genit Tract Dis 11:284-9. 2007
    ..Because of their rarity (3 previous cases in the literature), vaginal blue nevi have not previously been studied with immunohistochemical and ultrastructural analysis...
  18. pmc Cancer risk in DES daughters
    Janneke Verloop
    Department of Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    Cancer Causes Control 21:999-1007. 2010
    ..We examined long-term risk of cancer in women exposed to diethylstilbestrol (DES) in utero...
  19. ncbi Incidence of squamous neoplasia of the cervix and vagina in women exposed prenatally to diethylstilbestrol (United States)
    E E Hatch
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA
    Cancer Causes Control 12:837-45. 2001
    ..The purpose of the current study was to evaluate the long-term risk of developing high-grade squamous neoplasia of the genital tract among women exposed prenatally to DES...
  20. ncbi Sentinel node detection in a patient with recurrent endometrial cancer initially treated by hysterectomy and radiotherapy
    P van Dam
    Department of Obstetrics and Gynecology, Sint Augustinus Hospital, Antwerp, Belgium
    Int J Gynecol Cancer 14:673-6. 2004
    ..This unique case shows that sentinel node detection is possible after previous radiotherapy and surgery and hopes to stimulate further research in this field...
  21. ncbi Sentinel node detection in patients with vaginal carcinoma
    Peter Van Dam
    Department of Obstetrics and Gynecology, Sint Augustinus Hospital, Antwerp, Belgium
    Gynecol Oncol 92:89-92. 2004
    ..The objective was to describe sentinel ode detection in patients with primary and recurrent vaginal carcinoma...
  22. ncbi Definitive radiotherapy for patients with isolated vaginal recurrence of endometrial carcinoma after hysterectomy
    Anuja Jhingran
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 56:1366-72. 2003
    ..To determine the outcome of patients after radical radiotherapy (RT) for isolated vaginal recurrence of endometrial carcinoma and to determine the clinical and pathologic predictors of outcome...
  23. ncbi Sentinel node biopsy in vulvar and vaginal melanoma: presentation of six cases and a literature review
    Liana Abramova
    Department of Surgery, University of Virginia Health Science Center, Charlottesville, Virginia 22906, USA
    Ann Surg Oncol 9:840-6. 2002
    ..However, prophylactic lymphadenectomy has not been shown to improve survival of melanoma patients. We wanted to determine the feasibility of sentinel lymph node biopsy in patients with female urogenital melanoma as a staging procedure...
  24. ncbi High dose rate (192)Ir afterloading brachytherapy for cancer of the vagina
    D M Kushner
    Department of Obstertrics and Gynecology, University of Wisconsin Hospital and Clinics, H4 636 CSC, 600 Highland Avenue, Madison, WI 53792 3236, USA
    Br J Radiol 76:719-25. 2003
    ..Long-term follow-up is needed to further assess late complications, and larger studies are needed to confirm our results...
  25. ncbi Interstitial brachytherapy for salvage treatment of vaginal recurrences in previously unirradiated endometrial cancer patients
    Subir Nag
    Division of Radiation Oncology, Arthur G James Cancer Hospital and Solove Research Institute, Ohio State University, 300 W Tenth Avenue, Columbus, OH 43210, USA
    Int J Radiat Oncol Biol Phys 54:1153-9. 2002
    ..To evaluate whether interstitial brachytherapy can effectively salvage vaginal recurrence from endometrial carcinoma...
  26. pmc Cancer and developmental exposure to endocrine disruptors
    Linda S Birnbaum
    Experimental Toxicology Division, National Health and Environmental Effects Research Laboratory, Office of Research and Development, U S Environmental Protection Agency, Research Triangle Park, North Carolina, USA
    Environ Health Perspect 111:389-94. 2003
    ..Implications of these new findings suggest that causes of endocrine-related cancers or susceptibility to cancer may be a result of developmental exposures rather than exposures existing at or near the time of tumor detection...
  27. ncbi Effect of human papillomavirus vaccines on vulvar, vaginal, and anal intraepithelial lesions and vulvar cancer
    Monika Hampl
    Department of Gynecology and Obstetrics, Institute of Pathology, University Hospital, Heinrich Heine University, Duesseldorf, Germany
    Obstet Gynecol 108:1361-8. 2006
    ..We assessed the prevalence of HPV (and the types) to estimate the possible effect of a HPV vaccine on lower genital tract disease prevention...
  28. ncbi High-dose-rate (HDR) brachytherapy with or without external beam radiotherapy in the treatment of primary vaginal carcinoma: long-term results and side effects
    Ulrike Mock
    Department of Radiotherapy and Radiobiology, University Hospital Vienna, Vienna, Austria
    Int J Radiat Oncol Biol Phys 56:950-7. 2003
    ..To report toxicity, prognostic factors, and outcome of HDR brachytherapy in the primary management of vaginal carcinoma...
  29. ncbi The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the endometrium
    S Nag
    The Ohio State University, Columbus, OH 43210, USA
    Int J Radiat Oncol Biol Phys 48:779-90. 2000
    ..To develop recommendations for use of high-dose-rate (HDR) brachytherapy in patients with endometrial cancer...
  30. ncbi Comprehensive analysis of 130 multicentric intraepithelial female lower genital tract lesions by HPV typing and p16 expression profile
    Monika Hampl
    Department of Gynecology and Obstetrics, University Hospital of Duesseldorf, Moorenstr 5, 40 225 Duesseldorf, Germany
    J Cancer Res Clin Oncol 133:235-45. 2007
    ..In the current study, HPV infections and oncogene expression were assessed in a large series of patients with multicentric lower genital tract disease to analyze the transformation steps in extracervical disease...
  31. ncbi Management of a case of primary vaginal cancer with irreducible massive uterine prolapse--a case report
    A Karateke
    Department of Gynecological Oncology, Zeynep Kamil Women s and Children s Health and Education and Research Hospital, Istanbul, Turkey
    Eur J Gynaecol Oncol 27:528-30. 2006
    ..The cervix was bilaterally suspended to the pectineal ligaments by polypropylene mesh...
  32. ncbi Aggressive angiomyxoma of the vulva and vagina. A common problem: misdiagnosis
    Tayfun Gungor
    Department of Oncology, Zekai Tahir Burak Women s Health Education and Research Hospital, Ankara, Turkey
    Eur J Obstet Gynecol Reprod Biol 112:114-6. 2004
    ..Unfortunately, the pathological evaluation of the specimens revealed aggressive angiomyxoma. Misdiagnosis of this tumor is a common problem...
  33. ncbi Evaluating patients with mildly elevated transaminase levels
    Kimberly A Burns
    Laura Lee Blanton Gynecologic Oncology Center, University of Texas M D Anderson Cancer Center, Houston, USA
    Clin J Oncol Nurs 11:499-502. 2007
    ..At completion, her CA-125 normalized and imaging studies showed no evidence of disease. However, within three months, her CA-125 was elevated and a palpable mass at the vaginal apex was proven by biopsy to be recurrent disease...
  34. ncbi Vaginal cancer in a patient treated for cervical intraepithelial neoplasia (CIN 3): case report
    G Androutsopoulos
    Department of Obstetrics and Gynecology, Patras University Hospital, Rion, Greece
    Eur J Gynaecol Oncol 27:638-9. 2006
    ..In women who have undergone total hysterectomy for cervical intraepithelial neoplasia or cervical cancer, postoperative cytologic and colposcopic follow-up of the vagina is necessary...
  35. ncbi Small cell carcinoma of the female genital tract
    Sara Crowder
    Mid Missouri Gynecologic Oncology, Columbia, MO 65201, USA
    Semin Oncol 34:57-63. 2007
    ..Indeed, the majority of patients have an early demise with extensive distant disease. We review the clinical features, evaluation, and management of SCC of the female genital tract based on a comprehensive review of the literature...
  36. ncbi Predictors for long-term survival after interdisciplinary salvage surgery for advanced or recurrent gynecologic cancers
    M C Fleisch
    Universitaets Frauenklinik, Heinrich Heine Universitaet, Duesseldorf, Germany
    J Surg Oncol 95:476-84. 2007
    ..We wanted to identify factors which allow predicting long-term survival after pelvic exenteration (PE) for locally advanced or recurrent gynecologic malignancies...
  37. ncbi Recurrent endometrial cancer: patterns of recurrent disease and assessment of prognosis
    S A Sohaib
    Department of Radiology, Royal Marsden Hospital, London, UK
    Clin Radiol 62:28-34; discussion 35-6. 2007
    ..To evaluate patterns of disease and identify factors predicting outcome in patients presenting with recurrent endometrial adenocarcinoma following primary surgery...
  38. ncbi Early-stage vaginal carcinoma--an analysis of 70 patients
    G R Otton
    Queensland Centre for Gynaecological Cancer, Royal Women s Hospital, Brisbane, Australia
    Int J Gynecol Cancer 14:304-10. 2004
    ..The aims of this study were to assess outcomes and define prognostic factors for early-stage vaginal carcinoma...
  39. ncbi Rectovaginal radiation fistula repair using an obturator fasciocutaneous thigh flap
    Raphael C Lee
    Section of Plastic Surgery, Department of Surgery, The University of Chicago, 5812 South Ellis Avenue, Chicago, IL 60637, USA
    Gynecol Oncol 94:277-82. 2004
    ..Most often, either permanent colostomy or reconstruction with a well-vascularized flap is necessary. Traditional techniques for fistula repair utilize bulky muscle flaps, disfiguring pudendal artery flaps or may require laparotomy...
  40. ncbi Ultrasound-guided interstitial brachytherapy in the treatment of advanced vaginal recurrences from cervical and endometrial carcinoma
    Hajo Dirk Weitmann
    Universitätsklinik für Strahlentherapie und Strahlenbiologie, Allgemeines Krankenhaus der Stadt Wien, Wahringer Gurtel 18 20, 1090 Vienna, Austria
    Strahlenther Onkol 182:86-95. 2006
    ..In advanced vaginal recurrences of cervical and endometrial carcinomas therapeutic options are rare because of preceding therapy...
  41. ncbi Surgically (laparotomy/laparoscopy) guided placement of high dose rate interstitial irradiation catheters (LG-HDRT): technique and outcome
    James W Orr
    Florida Gynecologic Oncology, Lee Cancer Care, 2780 Cleveland Ave, Suite 717, Ft Myers, FL 33919, USA
    Gynecol Oncol 100:145-8. 2006
    ....
  42. ncbi Predictors of severe gastrointestinal toxicity after external beam radiotherapy and interstitial brachytherapy for advanced or recurrent gynecologic malignancies
    Mohit Kasibhatla
    Department of Radiation Oncology, Dartmouth Hitchcock Medical Center, Hanover, NH 03756, USA
    Int J Radiat Oncol Biol Phys 65:398-403. 2006
    ..0...
  43. ncbi MRI of vaginal conditions
    C Lopez
    Department of Radiology, Birmingham Women s Hospital, Birmingham, UK
    Clin Radiol 60:648-62. 2005
    ..In this paper, examples of the above are described and illustrated together with examples of the much rarer primary vaginal malignancies...
  44. ncbi Gynecologic cancers: factors affecting survival after pulmonary metastasectomy
    Jose M Clavero
    Division of General Thoracic Surgery, Rochester, Minnesota, USA
    Ann Thorac Surg 81:2004-7. 2006
    ..Little information is available regarding long-term survival after pulmonary metastasectomy for gynecologic malignancies...
  45. ncbi Primary mucinous adenocarcinoma of the vagina: possibility of differentiating from metastatic adenocarcinomas
    Maki Saitoh
    Department of Pathology, Yamagata University School of Medicine, Yamagata, Japan
    Pathol Int 55:372-5. 2005
    ..These findings indicate that the mucinous adenocarcinoma arose from vaginal adenosis. Further studies are necessary to investigate whether lack of sulfomucin expression is a characteristic feature of vaginal adenosis...
  46. ncbi Predictors of vaginal relapse in stage I endometrial cancer
    Andrea Mariani
    Section of Gynecologic Surgery, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Gynecol Oncol 97:820-7. 2005
    ..To identify factors predictive of vaginal relapse in stage I endometrial cancer, thereby potentially facilitating the selection of patients who may benefit from vaginal brachytherapy...
  47. ncbi Definitive radiation therapy for squamous cell carcinoma of the vagina
    Steven J Frank
    Division of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 62:138-47. 2005
    ..To evaluate outcome and describe clinical treatment guidelines for patients with primary squamous cell carcinoma of the vagina treated with definitive radiation therapy...
  48. ncbi Recurrence in a Schuchardt incision after Schauta-Amreich radical vaginal hysterectomy for cervical cancer
    A A Bader
    Department of Obstetrics and Gynecology, Medical University of Graz, Auenbruggerplatz 14, A 8036 Graz, Austria
    Int J Gynecol Cancer 16:1479-81. 2006
    ..Cervical cancers can implant and recur in perineal incisions. Thus, it appears prudent to avoid such incisions or, if they are made, to irrigate them copiously before closing them...
  49. ncbi Magnetic resonance-guided interstitial therapy for vaginal recurrence of endometrial cancer
    Akila N Viswanathan
    Department of Radiation Oncology, Brigham and Women s Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA
    Int J Radiat Oncol Biol Phys 66:91-9. 2006
    ..To evaluate the feasibility and to describe the acute toxicity of a real-time intraoperative magnetic resonance (MR)-image guided interstitial approach to treating vaginal recurrence of endometrial cancer...
  50. ncbi Hormonal replacement therapy after gynaecological cancer
    Nicoletta Biglia
    Institute for Cancer Research and Treatment IRCC, Academic Department of Gynaecological Oncology, University of Turin, Candiolo, Italy
    Gynakol Geburtshilfliche Rundsch 46:191-6. 2006
    ..The use of HRT in breast cancer patients is, at present, considered contra-indicated, even if results of clinical trials are not concordant. Therapeutic non-hormonal alternatives may be proposed to these patients...
  51. ncbi Gynecologic malignancies in women aged less than 25 years
    Whitney You
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Walter Reed Army Medical Center, Washington, DC 20307, USA
    Obstet Gynecol 105:1405-9. 2005
    ..To describe the epidemiologic characteristics of gynecologic malignancies in patients 25 years of age or younger...
  52. ncbi Is cytologic screening an effective surveillance method for detection of vaginal recurrence of uterine cancer?
    Amy L Cooper
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Kentucky Chandler Medical Center, Lexington, Kentucky 40536 0298, USA
    Obstet Gynecol 107:71-6. 2006
    ..The study objective was to assess the efficacy and costs associated with Pap tests in routine surveillance of women with uterine cancer...
  53. ncbi Laparoscopic-assisted radical parametrectomy including pelvic and/or paraaortic lymphadenectomy in women after prior hysterectomy-three cases
    Yoon S Lee
    Department of Obstetrics and Gynecology, Kyungpook National University, School of Medicine, 50 Samduk 2 Ga, Taegu, Korea 700 412
    Gynecol Oncol 91:619-22. 2003
    ..This type of surgery for invasive cervical cancer after a hysterectomy or vaginal stump metastasis traditionally requires a major laparotomy; however, a minimal-access approach is now being applied to this type of procedure...
  54. doi Stage II adenocarcinoma of the endometrium: adjuvant radiotherapy and recurrence patterns
    Scott C Cozad
    Therapeutic Radiologists, Inc, Liberty Radiation Oncology Clinic, Liberty, MO 64068, USA
    Int J Radiat Oncol Biol Phys 71:205-12. 2008
    ..Review patterns of recurrence for Stage II endometrial cancer in a community practice...
  55. doi MR imaging features of vaginal malignancies
    Jyoti H Parikh
    Department of Radiology, Royal Marsden Hospital NHS Foundation Trust, Fulham Road, London SW3 6JJ, United Kingdom
    Radiographics 28:49-63; quiz 322. 2008
    ..Most vaginal metastases occur by means of direct local spread from the cervix, uterus, or rectum. The MR imaging appearances of these metastases reflect the MR imaging appearances of the primary tumor...
  56. ncbi Time trends in the incidence of cervical and other genital squamous cell carcinomas and adenocarcinomas in Sweden, 1958-1996
    Kari Hemminki
    Department of Biosciences at Novum, Karolinska Institute, CNT Novum, 141 57 Huddinge, Sweden
    Eur J Obstet Gynecol Reprod Biol 101:64-9. 2002
    ..We wanted to examine reasons for the different incidence trends for cervical squamous cell carcinoma (SCC, declining) and adenocarcinoma (increasing)...
  57. doi Low-grade endometrial stromal sarcoma with florid intravenous component
    Keith Wing Kit Lo
    Department of Obstetrics and Gynecology, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, SAR, China
    Gynecol Obstet Invest 66:8-11. 2008
    ..Search for tumor involvement of the venous system at the time of diagnosis of metastasis or recurrence is essential. Surgical management of extensive venous recurrence of LGESS is feasible...
  58. ncbi The role of interstitial brachytherapy in the treatment of vaginal and vulvar malignancies
    Annedore R Seeger
    Department of Radiation Oncology, University of Erlangen Nuremberg, Erlangen, Germany
    Strahlenther Onkol 182:142-8. 2006
    ..Irradiation has established itself as a treatment for vulvar and vaginal malignancies. Due to the sensitive nature of the vulvar and vaginal tissues, interstitial brachytherapy (iBT) provides an effective, gentle and individualized therapy...
  59. doi Laparoscopic radical hysterectomy with vaginectomy and reconstruction of vagina in patients with stage I of primary vaginal carcinoma
    Bin Ling
    Department of Obstetrics and Gynecology, Anhui Provincial Hospital and Anhui Medical University, Hefei 230001, China
    Gynecol Oncol 109:92-6. 2008
    ....
  60. ncbi Radiographic imaging in gynecologic oncology
    J T Soper
    Division of Gynecologic Oncology, Box 3079, Duke University Medical Center, Durham, NC 27710, USA
    Clin Obstet Gynecol 44:485-94. 2001
    ..Further refinements of currently available techniques or newer techniques, however, are needed to increase the sensitivity for detection of subclinical or microscopic metastases in patients with gynecologic malignancies...
  61. ncbi Radiation therapy in endometrial cancer
    W J Koh
    Department of Radiation Oncology, University of Washington Medical Center, Seattle, WA 98195, USA
    Best Pract Res Clin Obstet Gynaecol 15:417-32. 2001
    ..In the meantime, we propose guidelines for radiotherapy in endometrial cancer which serve as bases for discussion and collaboration among physicians and as platforms for future study and progress...
  62. doi Cancer of the urinary bladder neovagina in a patient with Morris' syndrome
    Miroslaw Wielgos
    1st Department of Obstetrics and Gynecology, Medical University of Warsaw, Poland
    Onkologie 31:53-5. 2008
    ..Vaginal agenesis is a rare condition, therefore the incidence of a malignant transformation in the neovagina is extremely low...
  63. doi Lymphovascular space invasion does not predict vaginal relapses in stage I endometrioid adenocarcinoma of the endometrium
    Laurephile Desrosiers
    Department of Pathology, University of Massachusetts Medical Center, Worcester, MA 01605, USA
    Ann Diagn Pathol 12:112-7. 2008
    ..However, LVSI does not denote an increased likelihood of vaginal recurrences in S1EE. The presence of LVSI should not, in of itself, alter clinical staging, or trigger unnecessary therapeutic intervention...
  64. ncbi Tumor cell spillage to the vaginal cavity and vaginal stump during the surgery of endometrial carcinoma
    E Ryo
    Department of Obstetrics and Gynecology, Musashino Red Cross Hospital, and University of Tokyo, Tokyo, Japan
    Acta Obstet Gynecol Scand 80:364-7. 2001
    ..CONCLUSIONS: Endometrial carcinoma cells were spilled into the vaginal cavity in not a few cases and their spillage from there to the vaginal stump could follow during the surgery...
  65. ncbi Radiotherapy alone for invasive vaginal cancer: outcome with intracavitary high dose rate brachytherapy versus conventional low dose rate brachytherapy
    H Kucera
    Department of Gynecology, University of Vienna, Vienna, Austria
    Acta Obstet Gynecol Scand 80:355-60. 2001
    ..CONCLUSION: With HDRB and its advantages of decreased radiation exposure and patient immobilization and precise positioning, treatment results to be obtained are at least similar to traditional LDRB for primary vaginal cancer...
  66. pmc Lymphatic mapping and sentinel node biopsy in gynecological cancers: a critical review of the literature
    Ali Ayhan
    Department of Obstetrics and Gynecology, Division of Gynaecological Oncology, Baskent University School of Medicine, Ankara, Turkey
    World J Surg Oncol 6:53. 2008
    ....
  67. ncbi [Diagnosis of vulval and vaginal neoplasms with magnetic resonance imaging]
    E A Hauth
    Institut fur Diagnostische und Interventionelle Radiologie und Neuroradiologie, Universitatsklinikum Essen, Essen, Deutschland
    Gynakol Geburtshilfliche Rundsch 47:226-35. 2007
    ..MRI is useful in the pretherapeutic staging of vulval and vaginal neoplasms in order to assess tumor size, local tumor extent and presence of lymph node metastases...
  68. ncbi Radiation therapy for gynecologic cancer
    Krishnansu Sujata Tewari
    Division of Gynecologic Oncology, The University of California, Irvine 92868, USA
    J Obstet Gynaecol Res 28:123-40. 2002
  69. ncbi Transperineal high-dose-rate interstitial radiation therapy in the management of gynecologic malignancies
    Jun Itami
    Department of Radiation Therapy and Oncology, International Medical Center of Japan, Tokyo, Japan
    Strahlenther Onkol 179:737-41. 2003
    ..Clinical experience in high-dose-rate interstitial radiation therapy was retrospectively investigated...
  70. ncbi Sentinel lymph nodes in gynaecological malignancies: frontline between TNM and clinical staging systems?
    Katalin Zambo
    Department of Nuclear Medicine, Faculty of Medicine, University of Pecs, Pecs, Hungary
    Eur J Nucl Med Mol Imaging 30:1684-8. 2003
    ..The authors believe that sentinel node sampling is in fact a beneficial method in both early and advanced stage disease for determination of the tumour status and individualisation of surgical interventions...
  71. ncbi A comparative analysis of human papillomavirus types 16 and 18 and expression of p53 gene and Ki-67 in cervical, vaginal, and vulvar carcinomas
    Yasuko Koyamatsu
    Department of Obstetrics and Gynecology, Saga Medical School, Nabeshima, Saga, Japan
    Gynecol Oncol 90:547-51. 2003
    ..This study aimed to investigate the correlation between HPV positivity, p53 overexpression, and cell proliferative activity in cervical, vaginal, and vulvar squamous cell carcinoma...
  72. ncbi [Sentinel lymph notes in female reproductive tract cancer]
    Jing He Lang
    Department of Obstetrics and Gynecology, PUMC Hospital, CAMS and PUMC, Beijing 100730, China
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao 25:377-80. 2003
    ..Any definitive statements can be made to the validity of sentinel lymphadenectomy until we got data with long-term follow-up...
  73. ncbi Prognostic factors for outcomes and complications for primary squamous cell carcinoma of the vagina treated with radiation
    Phuoc T Tran
    Department of Radiation Oncology, Stanford Cancer Center, 875 Blake Wilbur Drive, Stanford, CA 94305, USA
    Gynecol Oncol 105:641-9. 2007
    ..To analyze the results of treatment and identify prognostic factors for primary squamous cell carcinoma (SCCA) of the vagina managed with radiotherapy at a single institution...
  74. ncbi Successful treatment of a high-grade intraepithelial neoplasia with imiquimod, with vulvar pemphigus as a side effect
    G Campagne
    Department of Obstetrics and Gynecology, Clinica Bella Medica, Partida Cap Negret 17, 03590 Altea, Spain
    Eur J Obstet Gynecol Reprod Biol 109:224-7. 2003
    ..The posterior biopsies confirm the absence of lesions but show drug-induced pemphigus as a side effect...
  75. ncbi A prospective study of the accuracy of 18Fluorodeoxyglucose positron emission tomography (18FDG PET) in identifying sites of metastasis prior to pelvic exenteration
    Amreen Husain
    Stanford University School of Medicine, Div of Gynecologic Oncology and Memorial Sloan Kettering Cancer Center, USA
    Gynecol Oncol 106:177-80. 2007
    ..To determine the accuracy of (18)FDG PET in identifying sites of metastatic disease prior to pelvic exenteration or radical resection in patients (pts) with recurrent cervical or vaginal cancers...
  76. ncbi [Clinical analysis of 42 cases of primary malignant melanoma in female genital tract]
    Ju Sheng An
    Department of Gynecologic Oncology, Cancer Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100021, China
    Zhonghua Fu Chan Ke Za Zhi 42:320-4. 2007
    ..To analyze the clinical characteristics, diagnosis, treatment and prognosis of primary malignant melanoma in female genital tract...
  77. ncbi Incidental diagnosis of primary vaginal adenocarcinoma of intestinal type: a case report and review of the literature
    Antonino Ditto
    Department of Gynecologic Oncology, Istituto Nazionale Tumori, Milan, Italy
    Int J Gynecol Pathol 26:490-3. 2007
    ..Concomitant chemoradiation, as a primary treatment, should be considered...
  78. ncbi Outcome and patterns of failure in pathologic stages I-IV clear-cell carcinoma of the endometrium: implications for adjuvant radiation therapy
    Kevin T Murphy
    Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL 60637, USA
    Int J Radiat Oncol Biol Phys 55:1272-6. 2003
    ..To evaluate the outcome and patterns of failure in women with uterine clear-cell carcinoma and discuss implications for adjuvant radiation therapy (RT)...
  79. ncbi Polymorphous low-grade adenocarcinoma of the vulva and vagina: a tumor resembling adenoid cystic carcinoma
    Stephanie Young
    Department of Pathology, Cook County Hospital, Chicago, IL 60612, USA
    Int J Surg Pathol 11:43-9. 2003
    ..PLGA should be added to the differential diagnosis of vulvar and vaginal neoplasia...
  80. ncbi Healing of vulvo-vaginal radionecrosis following revascularization
    Karen E Hoffman
    Department of Radiation Oncology, Massachusetts General Hospital, 100 Blossom Street, Boston, MA 02114, USA
    Gynecol Oncol 106:262-4. 2007
    ..Patient factors affect non-malignant tissue tolerance to radiation exposure...
  81. ncbi Vaginal neoplasms in infancy: the combined role of chemotherapy and conservative surgical resection
    C R McHenry
    Division of Pediatric Surgery, Children s Memorial Hospital, Chicago, IL 60614
    J Pediatr Surg 23:842-5. 1988
    ..One required a partial vaginectomy for local recurrence 21 months after initial presentation. Both patients are alive and disease-free 18 months and 4 years after surgery...
  82. ncbi Alcoholism and risk for cancer of the cervix uteri, vagina, and vulva
    E Weiderpass
    International Agency for Research on Cancer, Lyon, France
    Cancer Epidemiol Biomarkers Prev 10:899-901. 2001
    ..We conclude that alcoholic women are at high risk for in situ and invasive cervical cancer and for cancer of the vagina...
  83. ncbi The prevalence of tumors of the breast and female genital tract in Italy
    M Sant
    Epidemiology Division, National Cancer Institute (INT, Milan, Italy
    Tumori 85:382-6. 1999
    ..The prevalence of corpus uteri cancer decreased slightly in the elderly only, whereas that of cervix uteri cancer decreased at all ages...
  84. ncbi A population-based study of squamous cell vaginal cancer: HPV and cofactors
    Janet R Daling
    Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Seattle, Washington 98109 1024, USA
    Gynecol Oncol 84:263-70. 2002
    ..We conducted a study to evaluate risk factors for in situ and invasive vaginal cancer and their potential relationship to prior exposure to human papillomaviruses (HPV)...
  85. ncbi Risk of anogenital cancer after diagnosis of cervical intraepithelial neoplasia: a prospective population-based study
    Gustaf Edgren
    Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden
    Lancet Oncol 8:311-6. 2007
    ..Associations between HPV and vaginal, vulvar, and anal cancers are well established, but the full extent in terms of age and time since diagnosis of these associations is not well known...
  86. ncbi Descriptive epidemiology of vulvar and vaginal cancers in Vaud, Switzerland, 1974-1994
    F Levi
    Institut Universitaire de Medecine Sociale et Preventive, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
    Ann Oncol 9:1229-32. 1998
    ..To analyse trends in incidence, survival and risk of second neoplasms following vaginal and vulvar cancers using data collected by the Swiss Cancer Registry of Vaud over the 21-year period 1974-1994...
  87. pmc Leiomyosarcoma of the vagina: a case report and review from the literature
    Min Jung Suh
    Department of Obstetrics and Gynecology, St Vincent s Hospital, The Catholic University of Korea, Suwon, Korea
    J Gynecol Oncol 19:261-4. 2008
    Leiomyosarcomas comprise fewer than 2% of all malignant vaginal neoplasms. Due to their rarity, treatment for vaginal leiomyosarcomas have not been determined...
  88. ncbi Chemoradiation for primary invasive squamous carcinoma of the vagina
    J L Dalrymple
    University of California at Davis, Medical Center, Division of Gynecologic Oncology, Sacramento, CA 95817, USA
    Int J Gynecol Cancer 14:110-7. 2004
    ..To report outcomes for patients with primary, invasive, squamous carcinoma of the vagina treated with chemoradiation...
  89. ncbi Stage I squamous cell carcinoma of vagina complicating pregnancy: successful conservative treatment
    Kazuyuki Fujita
    Division of Molecular Genetics, Department of Obstetrics and Gynecology, Niigata University Graduate School of Medical and Dental Sciences, 1 757 Asahimachi dori, Niigata 951 8510, Japan
    Gynecol Oncol 98:513-5. 2005
    ..Vaginal squamous cell carcinoma in pregnancy is very rare situation...
  90. pmc Measurement of urinary beta core fragment of human chorionic gonadotrophin in women with vulvovaginal malignancy and its prognostic significance
    P G Carter
    Williamson Laboratory for Molecular Oncology, St Bartholomew s Hospital Medical College, West Smithfield, London, UK
    Br J Cancer 71:350-3. 1995
    ....
  91. ncbi Benign mixed tumour of the vagina: an unusual cause for postmenopausal bleeding
    N van den Broek
    Department of Obstetrics and Gynaecology, Royal Victoria Infirmary, Newcastle upon Tyne, UK
    Eur J Obstet Gynecol Reprod Biol 69:143-4. 1996
    ..The authors report an unusual case of post-menopausal bleeding in the form of a benign mixed tumour of the vagina...
  92. pmc Chemoprevention of mammary, cervix and nervous system carcinogenesis in animals using cultured Panax ginseng drugs and preliminary clinical trials in patients with precancerous lesions of the esophagus and endometrium
    V G Bespalov
    Group of Cancer Chemoprevention, N.N. Petrov, Research Institute of Oncology of the Ministry of Health of the Russian Federation, St. Petersburg, Russia
    J Korean Med Sci 16:S42-53. 2001
    ..Bioginseng induced the regression of adenomatous-cystic hyperplasia of the endometrium in some patients. Thus, we conclude that the drugs of ginseng appear to hold considerable promise for future cancer chemoprevention...
  93. doi [Infantile hemangioma. Successful treatment with propranolol]
    J Baetz
    Hautklinik des Universitätsklinikums Düsseldorf, Dusseldorf
    Hautarzt 61:290-2. 2010
    ..A few weeks after onset of the treatment, the size and color of hemangioma was obviously reduced; finally there was an almost complete regression. This result underlines the role of propranolol in treatment of problematic hemangioma...
  94. doi [Management of vaginal carcinoma in patients over 70 years old: advantage of a radiotherapy-brachytherapy association]
    Coralie Moncharmont
    Institut de Cancérologie Lucien Neuwirth, Departement de Radiotherapie, Saint Priest en Jarez, France
    Presse Med 42:e371-6. 2013
    ..Report and discuss the management of the primitive vaginal cancer in elderly adults at a single institute...
  95. ncbi Comparison of clinical efficacy of three different neoadjuvant approaches (chemotherapy combined vaginal intracavitary irradiation, neoadjuvant chemotherapy alone or radiotherapy) combined with surgery for patients with stage Ib2 and IIa2 cervical cancer
    Jian Hong Fu
    Department of Obstetrics and Gynecology, Radiotherapy, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, China
    Asian Pac J Cancer Prev 14:2377-81. 2013
    ....
  96. ncbi The evaluation of the sentinel node successfully conducted in a case of malignant melanoma of the vagina
    Shunsuke Nakagawa
    Department of Obstetrics and Gynecology, University of Tokyo, Hongo 7 3 1, Bunkyo ku, Tokyo 113 8655, Japan
    Gynecol Oncol 86:387-9. 2002
    ..To date, only one case was reported for successful detection of the sentinel node using a radiopharmaceutical-directed mapping technique in malignant melanoma of the vagina...
  97. ncbi The role of interstitial brachytherapy using template in locally advanced gynecological malignancies
    Prachi P Agrawal
    Department of Radiation Oncology, Gujarat Cancer and Research Institute, Ahmedabad, Gujarat, India
    Gynecol Oncol 99:169-75. 2005
    ....
  98. doi Primary Ewing's sarcoma/primitive neuroectodermal tumor of the vagina in a 54-year-old woman: a case report
    Xiaoyan Pang
    Department of Gynecology, The First Affiliated Hospital of China Medical University, Shenyang, 110001 Liaoning, People s Republic of China
    Arch Gynecol Obstet 285:1031-3. 2012
    ..Ewing's sarcoma (ES)/primitive neuroectodermal tumor (PNET) of the genital tract of women is uncommon. Presentation in vagina is exceedingly rare...
  99. doi [Rhabdomyoma of the vagina. Case report and short literature review]
    Tito Silvio Patrelli
    Universita degli Studi di Parma, Clinica Ginecologica ed Ostetrica, Parma, Italie
    Ann Pathol 32:53-7. 2012
    ..Local excision and subsequent pathological examination were performed. The final diagnosis was vaginal rhabdomyoma. The literature is reviewed and differential diagnosis are discussed...
  100. ncbi Adenoid cystic carcinoma of Bartholin's gland with lung metastasis: a case report
    X Wang
    Women s Hospital, School of Medicine, Zhejiang University, Hangzhou, China
    Eur J Gynaecol Oncol 30:317-20. 2009
    ..Adenoid cystic carcinoma (ACC) of the Bartholin's gland is very rare. There is no agreed consensus on the optimal treatment...
  101. doi The role of human papillomavirus type 16/18 genotyping in predicting high-grade cervical/vaginal intraepithelial neoplasm in women with mildly abnormal Papanicolaou results
    Ming Guo
    Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030 4009, USA
    Cancer Cytopathol 121:79-85. 2013
    ....

Research Grants44

  1. A Molecular Signature of Early Cervical Carcinoma
    Concepcion Diaz Arrastia; Fiscal Year: 2007
    ..I propose to identify a genomic and proteomic signature of cervical cancer that will predict the aggressive behavior of the tumor and function clinically to develop molecular-based treatment plans. ..
  2. Inflamation and the Risk of Endometrial Cancer
    Akila Viswanathan; Fiscal Year: 2007
    ..This proposal will ensure that she will become an established independent investigator and a leading expert in gynecologic cancer epidemiology. ..
  3. A Pilot Study Of Internet Recruitment and follow-up among Reproductive Age Women
    ELIZABETH HATCH; Fiscal Year: 2007
    ..If successful, we envision this study to be the first of more elaborate studies that employ the internet to enroll cohort members into long-term follow-up studies. ..
  4. CCBAR Workshop 2006-2007
    STACY LINDAU; Fiscal Year: 2007
    ....
  5. The Association between obesity, central adiposity and endocrine disruptors
    ELIZABETH HATCH; Fiscal Year: 2007
    ..The study is limited by its cross-sectional nature. Nevertheless, it may provide important clues for future, epidemiologic studies of the effect of these environmental contaminants on the risk of obesity. ..
  6. Gene Polymorphisms in Relation to Cancer in Black Women
    Julie Palmer; Fiscal Year: 2007
    ..The BWHS will provide the largest source of data on gene-environment interactions in black women, and will contribute substantially to the data available on young women of any race. ..
  7. Lifestyle Factors and Type 2 Diabetes in Black Women
    Julie Palmer; Fiscal Year: 2007
    ..Because the follow-up and data collection are funded by another grant, the proposed large study of modifiable risk factors for type 2 diabetes can be carried out at a relatively modest cost. ..
  8. Breast and Prostate Cancer Data Quality and Patterns of Care Study
    Xiaocheng Wu; Fiscal Year: 2007
    ..abstract_text> ..
  9. Progestin Actions in the Primate Breast and Uterus
    Charles Wood; Fiscal Year: 2007
    ..This work will have immediate public health relevance to postmenopausal women seeking the safest form of hormone therapy. ..
  10. Effect of Male Circumcision on Penile HPV Infection
    JENNIFER SUSAN SMITH; Fiscal Year: 2010
    ..If male circumcision is found to be effective and safe in reducing HPV infection or penile lesions in men, it could in turn reduce HPV prevalence and associated cervical neoplasia in women. ..
  11. An internet based prospective study of time to pregnancy
    Elizabeth E Hatch; Fiscal Year: 2010
    ..Identifying modifiable risk factors for infertility and miscarriage is an important public health goal, especially because the effectiveness of treatments for these conditions is relatively poor. ..
  12. CALCIUM CHANNEL BLOCKERS IN BREAST CANCER ETIOLOGY
    Janet Daling; Fiscal Year: 2001
    ..cimetidine, anti-depressants, lipid lowering drugs) frequently used by women in this age group. ..
  13. HRT USE AND RISK OF LOBULAR AND DUCTAL BREAST CANCER
    Janet Daling; Fiscal Year: 2004
    ..of CHRT associated with alteration in the histologic characteristics, tumor cell proliferation, or expression of steroid hormone receptors, oncogenes, and cell cycle and cell death regulator proteins of lobular and ductal breast cancers? ..
  14. Tamoxifen & Second Breast Cancer: Epidemiology/Pathology
    Janet Daling; Fiscal Year: 2004
    ..which women have increased or decreased risks of developing CBC if they use tamoxifen? (4) Among the CBC cases, how does tamoxifen alter the expression of these tumor markers in first compared to contralateral cancers? ..
  15. ELECTRIC INJURY--IMAGING OF THERMAL/NON-THERMAL ASPECTS
    Raphael Lee; Fiscal Year: 2003
    ..abstract_text> ..
  16. Biopolymer Surfactants for Sealing Electroporated Membranes
    Raphael Lee; Fiscal Year: 2007
    ..Finally, we will conduct studies in parallel to determine if surfactant rescued cells manifest normal phenotype during proliferation or exhibit effects of mutations caused by unrepaired DMA. ..